bicalutamide 50mg film-coated tablets
fresenius kabi oncology plc - bicalutamide - film-coated tablet - 50 milligram(s) - anti-androgens; bicalutamide
irinotecan 20 mg/ml concentrate for solution for infusion
fresenius kabi oncology plc - irinotecan hydrochloride trihydrate - concentrate for solution for infusion - 20 milligram(s)/millilitre - other antineoplastic agents; miltefosine
anastrozole 1 mg film-coated tablets
fresenius kabi oncology plc - anastrozole - film-coated tablet - 1 milligram(s) - aromatase inhibitors; anastrozole
gemcitabine 2 g powder for solution for infusion
fresenius kabi oncology plc - gemcitabine - powder for solution for infusion - 2 gram(s) - pyrimidine analogues; gemcitabine
gemcitabine 200 mg powder for solution for infusion
fresenius kabi oncology plc - gemcitabine - powder for solution for infusion - 200 milligram(s) - pyrimidine analogues; gemcitabine
gemcitabine 1 g powder for solution for infusion
fresenius kabi oncology plc - gemcitabine - powder for solution for infusion - 1 gram(s) - pyrimidine analogues; gemcitabine
letrozole
fresenius kabi oncology plc - letrozole - film coated tablet - 2.5 milligram - letrozole
bicalutamide 150 mg film-coated tablets
fresenius kabi oncology plc - bicalutamide - film-coated tablet - 150 milligram(s) - anti-androgens; bicalutamide
oxaliplatin 5 mg/ml pdr for soln for infusion
fresenius kabi oncology plc - oxaliplatin - pdr for soln for infusion - 5 mg/ml
oxaliplatin 5mg/ml concentrate for solution for infusion
fresenius kabi oncology plc - oxaliplatin - concentrate for solution for infusion - 5 milligram(s)/millilitre - platinum compounds; oxaliplatin